• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Perioperative Complications and Safety Evaluation of Robot-Assisted Radical Hysterectomy of Cervical Cancer After Neoadjuvant Chemotherapy.新辅助化疗后宫颈癌机器人辅助根治性子宫切除术的围手术期并发症及安全性评估
Cancer Manag Res. 2020 Jun 12;12:4483-4492. doi: 10.2147/CMAR.S243986. eCollection 2020.
2
Clavien-Dindo classification and risk prediction model of complications after robot-assisted radical hysterectomy for cervical cancer.Clavien-Dindo 分级与宫颈癌机器人辅助根治性子宫切除术术后并发症风险预测模型。
J Robot Surg. 2023 Apr;17(2):527-536. doi: 10.1007/s11701-022-01450-5. Epub 2022 Aug 1.
3
Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.新辅助化疗后对局部晚期宫颈癌女性进行机器人根治性子宫切除术的可行性
Eur J Surg Oncol. 2016 Sep;42(9):1372-7. doi: 10.1016/j.ejso.2016.04.060. Epub 2016 May 18.
4
Introduction of robot-assisted radical hysterectomy for early stage cervical cancer: impact on complications, costs and oncologic outcome.早期宫颈癌机器人辅助根治性子宫切除术的介绍:对并发症、成本和肿瘤学结局的影响
Acta Obstet Gynecol Scand. 2017 May;96(5):536-542. doi: 10.1111/aogs.13112. Epub 2017 Mar 6.
5
[Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy].[接受新辅助化疗的进展期胃癌患者全胃切除术后并发症的危险因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):153-159. doi: 10.3760/cma.j.cn.441530-20200905-00512.
6
Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score.应用改良手术 Apgar 评分预测宫颈癌机器人辅助根治性子宫切除术的围手术期并发症。
BMC Cancer. 2018 Sep 21;18(1):908. doi: 10.1186/s12885-018-4809-4.
7
Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: a case control study.新辅助化疗后腹腔镜与机器人根治性子宫切除术治疗局部晚期宫颈癌:病例对照研究。
Eur J Surg Oncol. 2015 Jan;41(1):142-7. doi: 10.1016/j.ejso.2013.08.018. Epub 2013 Sep 8.
8
Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity in Locally Advanced Cervical Carcinoma.新辅助化疗对局部晚期宫颈癌术后并发症的影响。
Cancer Res Treat. 2002 Jun;34(3):186-90. doi: 10.4143/crt.2002.34.3.186.
9
Robotic Versus Open Radical Hysterectomy in Women With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: A Single-institution Experience of Surgical and Oncologic Outcomes.新辅助化疗后局部晚期宫颈癌患者的机器人辅助与开放性根治性子宫切除术:单机构手术及肿瘤学结局经验
J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):909-16. doi: 10.1016/j.jmig.2016.04.014. Epub 2016 May 5.
10
Comparison of Robotic and laparoscopic Radical type-B and C hysterectomy for cervical cancer: Long term-outcomes.机器人辅助与腹腔镜下宫颈癌根治性B型和C型子宫切除术的比较:长期结果
Acta Biomed. 2017 Oct 23;88(3):289-296. doi: 10.23750/abm.v88i3.6100.

引用本文的文献

1
Comparison of rapid recovery outcomes between vNOTES hysterectomy and laparoscopic hysterectomy: a prospective study.单孔腹腔镜子宫切除术与腹腔镜子宫切除术快速恢复结局的比较:一项前瞻性研究。
BMC Surg. 2025 Apr 29;25(1):189. doi: 10.1186/s12893-025-02906-9.

本文引用的文献

1
Effect of laparoscopic versus abdominal radical hysterectomy on major surgical complications in women with stage IA-IIB cervical cancer in China, 2004-2015.腹腔镜与经腹根治性子宫切除术治疗中国 2004-2015 年 IA-IIB 期宫颈癌患者主要手术并发症的效果。
Gynecol Oncol. 2020 Jan;156(1):115-123. doi: 10.1016/j.ygyno.2019.10.032. Epub 2019 Dec 2.
2
Efficacy of different surgical approaches in the clinical and survival outcomes of patients with early-stage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China.不同手术入路在早期宫颈癌患者临床结局和生存预后中的疗效:中国一项 III 期多中心随机对照临床试验方案。
BMJ Open. 2019 Jul 29;9(7):e029055. doi: 10.1136/bmjopen-2019-029055.
3
Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study.新辅助化疗后行根治性子宫切除术治疗 IB2 期至 IIB 期宫颈癌:一项回顾性队列研究。
Int J Clin Oncol. 2019 Nov;24(11):1440-1448. doi: 10.1007/s10147-019-01510-1. Epub 2019 Jul 15.
4
Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.手术方式对宫颈癌根治性子宫切除术患者肿瘤学结局的影响。
Am J Obstet Gynecol. 2019 Dec;221(6):619.e1-619.e24. doi: 10.1016/j.ajog.2019.07.009. Epub 2019 Jul 6.
5
Predictive factors of severe perioperative morbidity of radical hysterectomy with lymphadenectomy in early-stage cervical cancer: A French prospective multicentric cohort of 248 patients.早期宫颈癌根治性子宫切除术加淋巴结切除术围手术期严重并发症的预测因素:法国前瞻性多中心 248 例队列研究。
Eur J Surg Oncol. 2019 Apr;45(4):650-658. doi: 10.1016/j.ejso.2018.10.057. Epub 2018 Oct 17.
6
Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis.新辅助化疗联合根治性手术与单纯根治性手术治疗宫颈癌的系统评价和荟萃分析
Onco Targets Ther. 2019 Mar 7;12:1881-1891. doi: 10.2147/OTT.S186451. eCollection 2019.
7
Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution.机器人手术与开腹根治性子宫切除术治疗 IB1 期宫颈癌的疗效比较:单中心大样本研究结果。
Gynecol Oncol. 2019 May;153(2):242-247. doi: 10.1016/j.ygyno.2019.03.001. Epub 2019 Mar 6.
8
Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.盆腔廓清术治疗妇科恶性肿瘤的疗效和结局:一项基于人群的研究。
Gynecol Oncol. 2019 May;153(2):368-375. doi: 10.1016/j.ygyno.2019.02.002. Epub 2019 Feb 19.
9
Cervical cancer.宫颈癌。
Lancet. 2019 Jan 12;393(10167):169-182. doi: 10.1016/S0140-6736(18)32470-X.
10
Short-term outcomes of robotic-assisted versus conventional laparoscopic radical hysterectomy for early-stage cervical cancer: A single-center study.机器人辅助与传统腹腔镜根治性子宫切除术治疗早期宫颈癌的短期结局:一项单中心研究。
J Obstet Gynaecol Res. 2019 Feb;45(2):405-411. doi: 10.1111/jog.13858. Epub 2018 Nov 13.

新辅助化疗后宫颈癌机器人辅助根治性子宫切除术的围手术期并发症及安全性评估

Perioperative Complications and Safety Evaluation of Robot-Assisted Radical Hysterectomy of Cervical Cancer After Neoadjuvant Chemotherapy.

作者信息

Chang Wei-Fu, Luo Ai-Jing, Yuan Yi-Feng, Chen Yang, Xin Zi-Rui, Xu Shuai-Shuai

机构信息

Xiangya School of Public Health, Central South University, Changsha 410008, Hunan, People's Republic of China.

The Third Xiangya Hospital of Central South University, Changsha 410013, Hunan, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Jun 12;12:4483-4492. doi: 10.2147/CMAR.S243986. eCollection 2020.

DOI:10.2147/CMAR.S243986
PMID:32606942
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7305848/
Abstract

PURPOSE

To evaluate the perioperative complications of patients with cervical cancer who are treated with robot-assisted radical hysterectomy (RRH) and to further evaluate the safety of patients undergoing NACT.

METHODS

A total of 805 consecutive cervical cancer patients undergoing RRH were involved in this report. Their clinical characteristics were retrieved from hospital medical records. Perioperative complications were subdivided into intraoperative and postoperative complications, which were graded according to the Clavien-Dindo classification (CDC), and the complications of grade III and above were defined as severe complications. Furthermore, the two-level logistic regression model was used to estimate the risk factors of perioperative and severe complications and to further confirm the relationship between NACT and perioperative and severe complications.

RESULTS

The perioperative complication rate and severe complications were 45.09% and 7.83%, respectively. Poorly differentiated tumor and NACT were identified as independent risk factors for perioperative complications by multifactor analysis. Furthermore, we concentrated on the relations between NACT and complications. The risk of perioperative complications of the group with NACT (OR = 11.08, 95% CI: 5.70-21.54) was significantly higher than the group without NACT, especially in postoperative complications (OR=17.65, 95% CI: 8.63-36.08), even after adjusting confounding factors. However, there was no statistically significant difference in terms of severe complications (OR=1.68, 95% CI: 0.64-4.41) and intraoperative complications (OR=0.51, 95% CI: 0.18-1.41). Moreover, as the times of NACT increase, the impact on perioperative complications is more pronounced. A similar trend was observed in postoperative complications, while this statistical difference was still not observed in intraoperative and severe complications.

CONCLUSION

This result demonstrates the feasibility and safety of RRH of cervical carcinoma after NACT in generally, since it only causes mild complications, not severe complications.

摘要

目的

评估接受机器人辅助根治性子宫切除术(RRH)治疗的宫颈癌患者的围手术期并发症,并进一步评估接受新辅助化疗(NACT)患者的安全性。

方法

本报告纳入了805例连续接受RRH治疗的宫颈癌患者。从医院病历中获取他们的临床特征。围手术期并发症分为术中并发症和术后并发症,根据Clavien-Dindo分类(CDC)进行分级,III级及以上并发症定义为严重并发症。此外,采用二级逻辑回归模型估计围手术期和严重并发症的危险因素,并进一步确认NACT与围手术期和严重并发症之间的关系。

结果

围手术期并发症发生率和严重并发症发生率分别为45.09%和7.83%。多因素分析确定低分化肿瘤和NACT为围手术期并发症的独立危险因素。此外,我们重点关注了NACT与并发症之间的关系。接受NACT组的围手术期并发症风险(OR = 11.08,95%CI:5.70 - 21.54)显著高于未接受NACT组,尤其是术后并发症(OR = 17.65,95%CI:8.63 - 36.08),即使在调整混杂因素后也是如此。然而,在严重并发症(OR = 1.68,95%CI:0.64 - 4.41)和术中并发症(OR = 0.51,95%CI:0.18 - 1.41)方面没有统计学显著差异。此外,随着NACT次数的增加,对围手术期并发症的影响更为明显。术后并发症也观察到类似趋势,而在术中并发症和严重并发症中仍未观察到这种统计学差异。

结论

该结果总体上证明了NACT后宫颈癌RRH的可行性和安全性,因为它仅引起轻度并发症,而非严重并发症。